AstronauTx has exercised its option to acquire worldwide rights to [...]

Vaximm AG has completed analysis of two clinical studies evaluating [...]

Aravax’s PVX108 has received FDA Fast Track designation as the [...]

Verdiva Bio has dosed the first patient in a Phase [...]

AI-driven antibody discovery could create a $7 billion market opportunity [...]

CAMP4 Therapeutics has received Australian regulatory and ethics clearance to [...]

Novogene Europe has expanded its single-cell RNA sequencing capability at [...]

etherna, a biotech company specialising in mRNA and lipid nanoparticle [...]

Hansa Biopharma’s Biologics License Application (BLA) for imlifidase has been [...]

Nuclera has extended its Series C funding to a total [...]